Home › Funds › GDS Wealth Management › EW

GDS Wealth Management position in EW

EDWARDS LIFESCIENCES CORP · Health Care

GDS Wealth Management reported holding 251,883 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$21.7M, representing 0.97% of its reported portfolio and ranking #42 among its reported holdings. GDS Wealth Management has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)251.88K sh
Reported value held$21.74M
Portfolio Weight0.97%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How GDS Wealth Management's EW position evolved

GDS Wealth Management first disclosed a stake in EW in Q3 2023 at 91,881 shares (US$6.4M). The position peaked in Q2 2026 at 266,372 shares, worth US$24.1M. Across 13 filings, GDS Wealth Management increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 251,883 shares valued at US$21.7M — a reduction of -14,489 shares quarter over quarter.. Notable position changes include a 98% increase in Q4 2023 (shares rose 25% over the following quarter), a 33% trim in Q3 2024 (shares rose 12% over the following quarter), a 46% increase in Q4 2024 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 91.88K $6.37M New
Q4 2023 182.21K $13.89M Add
Q1 2024 187.63K $17.93M Add
Q2 2024 194.39K $17.96M Add
Q3 2024 130.67K $8.62M Reduce
Q4 2024 191.01K $14.14M Add
Q1 2025 206.62K $14.98M Add
Q2 2025 216.95K $16.97M Add
Q3 2025 226.00K $17.58M Add
Q4 2025 232.88K $19.85M Add
Q1 2026 247.61K $19.83M Add
Q2 2026 266.37K $24.10M Add
Q3 2026 251.88K $21.74M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 31 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has GDS Wealth Management held EW?

GDS Wealth Management has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is GDS Wealth Management's current position in EW?

As of Q3 2026, GDS Wealth Management holds 251.88K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $21.74M, representing 0.97% of its reported portfolio and ranking #42.

Has GDS Wealth Management been buying or selling EW?

In the latest 13F filing (Q3 2026), GDS Wealth Management reduced its position in EW. The position peaked in Q2 2026 at 266.37K shares.

Which other funds hold EW?

Other major institutional holders of EW include Belvedere Trading LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.